These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26928386)

  • 1. Copper that cancer with lysosomal love!
    Kovacevic Z; Sahni S; Richardson DR
    Aging (Albany NY); 2016 Feb; 8(2):210-1. PubMed ID: 26928386
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.
    Lovejoy DB; Jansson PJ; Brunk UT; Wong J; Ponka P; Richardson DR
    Cancer Res; 2011 Sep; 71(17):5871-80. PubMed ID: 21750178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding.
    Park KC; Geleta B; Leck LYW; Paluncic J; Chiang S; Jansson PJ; Kovacevic Z; Richardson DR
    J Biol Chem; 2020 Jan; 295(2):481-503. PubMed ID: 31744884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC.
    Seebacher NA; Richardson DR; Jansson PJ
    Cell Death Dis; 2016 Dec; 7(12):e2510. PubMed ID: 27906178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).
    Gutierrez EM; Seebacher NA; Arzuman L; Kovacevic Z; Lane DJ; Richardson V; Merlot AM; Lok H; Kalinowski DS; Sahni S; Jansson PJ; Richardson DR
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1665-81. PubMed ID: 27102538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).
    Jansson PJ; Yamagishi T; Arvind A; Seebacher N; Gutierrez E; Stacy A; Maleki S; Sharp D; Sahni S; Richardson DR
    J Biol Chem; 2015 Apr; 290(15):9588-603. PubMed ID: 25720491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.
    Al-Akra L; Bae DH; Sahni S; Huang MLH; Park KC; Lane DJR; Jansson PJ; Richardson DR
    J Biol Chem; 2018 Mar; 293(10):3562-3587. PubMed ID: 29305422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Relationships of Di-2-pyridylketone, 2-Benzoylpyridine, and 2-Acetylpyridine Thiosemicarbazones for Overcoming Pgp-Mediated Drug Resistance.
    Stacy AE; Palanimuthu D; Bernhardt PV; Kalinowski DS; Jansson PJ; Richardson DR
    J Med Chem; 2016 Sep; 59(18):8601-20. PubMed ID: 27524608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.
    Gutierrez E; Richardson DR; Jansson PJ
    J Biol Chem; 2014 Nov; 289(48):33568-89. PubMed ID: 25301941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting autophagy in antitumor agent design: furthering the 'lysosomal love' strategy.
    Sahni S; Kovacevic Z; Kalinowski DS; Huang M; Menezes S; Krishan S; Lane DJ; Jansson PJ; Richardson DR
    Future Med Chem; 2016 May; 8(7):727-9. PubMed ID: 27149429
    [No Abstract]   [Full Text] [Related]  

  • 11. The redox-active, anti-cancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism.
    Kalinowski DS; Jansson PJ; Kovacevic Z; Richardson DR
    Redox Rep; 2013; 18(2):48-50. PubMed ID: 23433485
    [No Abstract]   [Full Text] [Related]  

  • 12. Reaction of copper complexes with Ehrlich cells.
    Petering DH
    Adv Exp Med Biol; 1977; 91():179-91. PubMed ID: 75680
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells.
    Krishan S; Sahni S; Leck LYW; Jansson PJ; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165657. PubMed ID: 31904416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal transport capabilities of anticancer copper chelators.
    Gaál A; Orgován G; Mihucz VG; Pape I; Ingerle D; Streli C; Szoboszlai N
    J Trace Elem Med Biol; 2018 May; 47():79-88. PubMed ID: 29544811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mode of action of the copper(II)chelate of 2-keto-3-ethoxybutyraldehyde-bis(thiosemicarbazone).
    Bhuyan BK; Betz T
    Cancer Res; 1968 Apr; 28(4):758-63. PubMed ID: 5649064
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of metals in the antitumor action of 1,5-bisthiosemicarbazones.
    Kessel D; McElhinney RS
    Mol Pharmacol; 1975 May; 11(3):298-309. PubMed ID: 1170492
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor effects of bis-thiosemicarbazones--inhibition of deoxyribonucleic acid synthesis in vitro.
    Kessel D; McElhinney RS
    Biochem Pharmacol; 1975 Jan; 24(1):133-7. PubMed ID: 1092303
    [No Abstract]   [Full Text] [Related]  

  • 18. The anticancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism.
    Gundelach JH; Madhavan AA; Wettstein PJ; Bram RJ
    FASEB J; 2013 Feb; 27(2):782-92. PubMed ID: 23134680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect.
    Quach P; Gutierrez E; Basha MT; Kalinowski DS; Sharpe PC; Lovejoy DB; Bernhardt PV; Jansson PJ; Richardson DR
    Mol Pharmacol; 2012 Jul; 82(1):105-14. PubMed ID: 22508546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel, quinone-thiosemicarbazone hybrid (QTSCHY) non-platinum antitumor agents: inhibition of DNA biosynthesis in P388 lymphocytic cells by coordinatively unsaturated copper(II) and iron(III) complexes of naphthoquinone thiosemicarbazones.
    Padhye S; Chikate R; Kumbhar A; Shallom JM; Chitnis MP
    Biometals; 1992; 5(2):67-71. PubMed ID: 1525479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.